Good Practice Guide: Harmonizing the Definition and Use of NIMPs

Good Practice Guides

Digital

Member Price

$95.00

Non-Member Price

$395.00

Buy Now

Published: January 2013
Pages: 56

Table of Contents
Special Pricing for Emerging Economies

Recent survey results show that the pharmaceutical companies often take an overly conservative approach to NIMPs (or Non-IMPs) due to regulatory and operational ambiguity. This can lead to unnecessary expenses and process steps, which can needlessly complicate clinical trials.

The ISPE Good Practice Guide: Harmonizing the Definition and Use of Non-Investigational Medicinal Products (NIMPs) aims to provide practical operational guidance and drive a consistent industry approach to the use of NIMPs. The Guide contains criteria for classifying NIMPs and an overview of current NIMP regulatory requirements.

This in-depth Guide will help you properly manage NIMPs by providing guidance on:

Guidance Document License Agreement

The contents of ISPE’s guidance documents, both printed and digital, are protected by law and intended solely for the personal non-commercial use of the individual purchaser.

Reproduction of multiple copies of these materials, in whole or in part, for the purposes of commercial distribution is prohibited.

Membership discounts are available only to current members and are intended for individual use of the guides, not for resale.

View Agreement

Good Practice Guide: Harmonizing the Definition and Use of NIMPs

Digital

Emerging Economy Publication Discount

Guidance Document Resources A to Z

ISPE Membership